Belvedere Trading »

Fusion Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $878k 41k 21.32

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding Fusion Pharmaceuticals

Federated Investors
Perceptive Advisors
Avidity Partners Management
Deerfield Management Company
Fil
Pentwater Capital Management
Johnson & Johnson
Millennium Management
Tpg Gp A
TIG Advisors
FMR
Marshall Wace
Verition Fund Management
Qube Research & Technologies
William Blair $ Company

View all funds holding Fusion Pharmaceuticals